Reports have also emphasized that such compounds are active inhibitors in cholesteryl ester transfer protein (CETP) and acyl-CoA:cholesterol acyltransferase (ACAT), which promote the therapeutic potential of atherosclerosis [18]. The gene discussed is CETP; the disease is atherosclerosis.